388 related articles for article (PubMed ID: 6116654)
1. [Effects of a new histamine H2-receptor antagonist, ranitidine, on experimental acute gastric and duodenal ulcers (author's transl)].
Okabe S; Kunimi H; Ohtsuki H
Nihon Yakurigaku Zasshi; 1981 Apr; 77(4):397-406. PubMed ID: 6116654
[TBL] [Abstract][Full Text] [Related]
2. Effects of cimetidine, a histamine H2-receptor antagonist, on various experimental gastric and duodenal ulcers.
Okabe S; Takeuchi K; Urushidani T; Takagi K
Am J Dig Dis; 1977 Aug; 22(8):677-84. PubMed ID: 18007
[TBL] [Abstract][Full Text] [Related]
3. [Effects of ranitidine, a new histamine H2-receptor antagonist, on histamine- and aspirin-induced gastric ulcers in rats and dogs (author's transl)].
Okabe S; Tabata K; Ohtsuki H
Nihon Yakurigaku Zasshi; 1981 Dec; 78(6):549-55. PubMed ID: 6120886
[TBL] [Abstract][Full Text] [Related]
4. [Effects of ranitidine, a new histamine H2-receptor antagonist, on secretagogue-stimulated gastric secretion in rats: comparison with cimetidine (author's transl)].
Okabe S; Kawakami M
Nihon Yakurigaku Zasshi; 1981 Aug; 78(2):57-62. PubMed ID: 6119281
[TBL] [Abstract][Full Text] [Related]
5. The effect of the new H2-receptor antagonist mifentidine on gastric secretion, gastric emptying and experimental gastric and duodenal ulcers in the rat: comparison with cimetidine and ranitidine.
Scarpignato C; Tangwa M; Tramacere R; Del Soldato P
Digestion; 1986; 33(1):7-16. PubMed ID: 2866139
[TBL] [Abstract][Full Text] [Related]
6. Pharmacology and clinical efficacy of ranitidine, a new H2-receptor antagonist.
Helman CA; Tim LO
Pharmacotherapy; 1983; 3(4):185-92. PubMed ID: 6136952
[TBL] [Abstract][Full Text] [Related]
7. Cimetidine, ranitidine and mifentidine in specific gastric and duodenal ulcer models.
Del Soldato P; Ghiorzi A; Cereda E; Donetti A
Pharmacology; 1985; 30(1):45-51. PubMed ID: 2858110
[TBL] [Abstract][Full Text] [Related]
8. Effects of cimetidine and atropine sulfate on gastric secretion and healing of gastric and duodenal ulcers in rats.
Okabe S; Takeuchi K; Murata T; Takagi K
Eur J Pharmacol; 1977 Jan; 41(2):205-8. PubMed ID: 12989
[TBL] [Abstract][Full Text] [Related]
9. Comparison of ranitidine and cimetidine in the inhibition of histamine, sham-feeding, and meal-induced gastric secretion in duodenal ulcer patients.
Konturek SJ; Obtulowicz W; Kwiecien N; Sito E; Mikos E; Oleksy J
Gut; 1980 Mar; 21(3):181-6. PubMed ID: 6105116
[TBL] [Abstract][Full Text] [Related]
10. Gastric antisecretory and antiulcer activity of oxytocin in rats and guinea pigs.
Asad M; Shewade DG; Koumaravelou K; Abraham BK; Vasu S; Ramaswamy S
Life Sci; 2001 Nov; 70(1):17-24. PubMed ID: 11764003
[TBL] [Abstract][Full Text] [Related]
11. Effects of 5-acetylspiro[benzofuran-2(3H),1'-cyclopropan]-3-one, a new anti-ulcer agent, on experimental acute and chronic ulcers.
Inatomi N; Hirata T; Inada I; Satoh H; Sino A; Maki Y
Arzneimittelforschung; 1985; 35(10):1553-9. PubMed ID: 4074415
[TBL] [Abstract][Full Text] [Related]
12. [Effects of nizatidine, a new histamine H2-receptor antagonist, on gastric acid secretion and various gastric and duodenal lesions in rats: comparison with cimetidine].
Okabe S; Takeuchi K; Okada M; Kumadaki Y; Nakata M; Nakata H
Nihon Yakurigaku Zasshi; 1989 Mar; 93(3):133-44. PubMed ID: 2567267
[TBL] [Abstract][Full Text] [Related]
13. [Effects of ranitidine, a new histamine H2-receptor antagonist, on secretagogue-stimulated gastric secretion in Heidenhain pouch dogs (author's transl)].
Ohtsuki H; Okabe S
Nihon Yakurigaku Zasshi; 1981 Dec; 78(6):539-47. PubMed ID: 6120885
[TBL] [Abstract][Full Text] [Related]
14. A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine.
Cavanagh RL; Usakewicz JJ; Buyniski JP
J Pharmacol Exp Ther; 1983 Jan; 224(1):171-9. PubMed ID: 6129316
[TBL] [Abstract][Full Text] [Related]
15. [Effects of IGN-2098, a new histamine H2-receptor antagonist, on gastric secretion and gastric and duodenal lesions induced in rats. Comparison with roxatidine].
Okabe S; Narita M; Nakaji S; Takinami Y; Kawano O; Misaki N
Nihon Yakurigaku Zasshi; 1992 Mar; 99(3):167-80. PubMed ID: 1354631
[TBL] [Abstract][Full Text] [Related]
16. FR145715, a novel histamine H2 receptor antagonist, with specific anti-Helicobacter pylori activities.
Ishikawa H; Ito H; Higaki M; Higaki M; Matsumoto Y; Kamimura T; Katsura Y; Tomishi T; Inoue Y; Takasugi H; Tomoi M; Krakowka S; Yoshida K
Eur J Pharmacol; 1999 Aug; 378(3):299-310. PubMed ID: 10493106
[TBL] [Abstract][Full Text] [Related]
17. [Ranitidine, a new histamine H2 receptor antagonist. First experimental and clinical data].
Simon B; Dammann HG; Müller P; Kather H
Minerva Med; 1981 Oct; 72(40):2657-61. PubMed ID: 6117040
[TBL] [Abstract][Full Text] [Related]
18. Ranitidine--pharmacology and clinical use.
Dawson J; Richards DA; Stables R; Dixon GT; Cockel R
J Clin Hosp Pharm; 1983 Mar; 8(1):1-13. PubMed ID: 6132928
[No Abstract] [Full Text] [Related]
19. Effect of ranitidine, a new H2-antagonist, on gastric and pancreatic secretion in duodenal ulcer patients.
Konturek SJ; Obtułowicz W; Kwiecień N; Sito E; Oleksy J; Miszczuk-Jamska B
Dig Dis Sci; 1980 Oct; 25(10):737-43. PubMed ID: 6107221
[TBL] [Abstract][Full Text] [Related]
20. [Acid anti-secretion therapy in gastric and duodenal ulcer].
Lattanzi A
Clin Ter; 1981 Oct; 99(2):187-205. PubMed ID: 6119184
[No Abstract] [Full Text] [Related]
[Next] [New Search]
